Nature's Sunshine Products, Inc. (NATR): Price and Financial Metrics
Nature's Sunshine Products, Inc. (NATR)
Today's Latest Price: $9.85 USD
Updated Jul 16 12:00pm
Add NATR to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 14 in Medical - Consumer Goods
See all "A" rated Strong Buy stocks
NATR Stock Summary
- The ratio of debt to operating expenses for Natures Sunshine Products Inc is higher than it is for about merely 12.5% of US stocks.
- In terms of twelve month growth in earnings before interest and taxes, Natures Sunshine Products Inc is reporting a growth rate of 238.18%; that's higher than 94.23% of US stocks.
- The volatility of Natures Sunshine Products Inc's share price is greater than that of only 8.46% US stocks with at least 200 days of trading history.
- Stocks that are quantitatively similar to NATR, based on their financial statements, market capitalization, and price volatility, are NBEV, MTEX, JBLU, RELV, and COTY.
- NATR's SEC filings can be seen here. And to visit Natures Sunshine Products Inc's official web site, go to www.naturessunshine.com.
NATR Stock Price Chart Technical Analysis Charts
NATR Price/Volume Stats
| Current price | $9.85 | 52-week high | $10.85 |
| Prev. close | $10.02 | 52-week low | $5.50 |
| Day low | $9.78 | Volume | 1,839 |
| Day high | $10.00 | Avg. volume | 29,268 |
| 50-day MA | $9.11 | Dividend yield | N/A |
| 200-day MA | $9.07 | Market Cap | 191.81M |
Nature's Sunshine Products, Inc. (NATR) Company Bio
Nature's Sunshine Products markets and distributes nutritional and personal care products. The company was founded in 1972 and is based in Lehi, Utah.
NATR Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $9.85 | $427.48 | 4381% |
Below please find a table outlining a discounted cash flow forecast for NATR, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Natures Sunshine Products Inc ranked in the 94th percentile in terms of potential gain offered. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 4403%. In terms of the factors that were most noteworthy in this DCF analysis for NATR, they are:
- The business' balance sheet reveals debt to be 11% of the company's capital (with equity being the remaining amount). Approximately merely 23.78% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
- The company's cost of debt, derived from its interest coverage, tax rate, and market capitalization, is greater than merely 0% of stocks in its sector (Consumer Defensive).
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 4293% |
| 1% | 4337% |
| 2% | 4381% |
| 3% | 4425% |
| 4% | 4469% |
| 5% | 4513% |
ACI, CRESY, TANH, ELF, and ACU can be thought of as valuation peers to NATR, in the sense that they are in the Consumer Defensive sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...